\n
References: 1.<\/strong> Ashe K, Kelso W, Farrand S, et al. Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments. Front Psychiatry. 2019;10:561. doi:10.3389\/fpsyt.2019.00561. 2.<\/strong> Vockley J, Andersson HC, Antshel KM, et al. American College of Medical Genetics and Genomics Therapeutic Committee. Phenylalanine hydroxylase deficiency: diagnosis and management guidelines. Genet Med<\/em>. 2014;16(2):188-200. 3.<\/strong> Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet<\/em>. 2010;376(9750):1417-1427. 4.<\/strong> Rocha JC, MacDonald A. Treatment options and dietary supplements for patients with phenylketonuria. Expert Opin Orphan Drugs<\/em>. 2018;6(11):667-681. 5.<\/strong> van Wegberg AMJ, MacDonald A, Ahring K, et al. The complete European guidelines of phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis<\/em>. 2017;12(1):162. doi:10.1186\/s13023-017-0685-2. 6.<\/strong>\u00a0van Spronsen FJ, Blau N, Harding C, et al. Phenylketonuria. Nat Rev Dis Primers<\/em>. 2021;7(1):36. doi:10.1038\/s41572-021-00267-0. 7<\/strong>.<\/strong> Anderson PJ, Leuzzi V. White matter pathology in phenylketonuria. Mol Genet Metab. 2010;99(suppl 1):S3-S9. 8. <\/strong>Christ SE, Price MH, Bodner KE, Saville C, Moffitt AJ, Peck D. Morphometric analysis of gray matter integrity in individuals with early-treated phenylketonuria. Mol Genet Metab<\/em>. 2016;118(1):3-8. 9.<\/strong> White DA, Antenor-Dorsey JV, Grange DK, et al. White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria. Mol Genet Metab<\/em>. 2013;110(3):213\u2013217. 10.<\/strong> Schuck PF, Malgarin F, Cararo JH, Cardoso F, Streck EL, Ferreira GC. Phenylketonuria pathophysiology: on the role of metabolic alterations. Aging Dis. 2016;6(5):390-399. 11.<\/strong> Adler-Abramovich L, Vaks L, Carny O, et al. Phenylalanine assembly into toxic fibrils suggest amyloid etiology in phenylketonuria. Nat Chem Biol<\/em>. 2012;8(8):701-706.<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":205,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"acf":[],"yoast_head":"\nGenetics and pathophysiology of phenylketonuria (PKU)<\/title>\n \n \n \n \n \n \n \n \n \n \n \n